Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Juncal VR, Abdo Jorge F, Paranhos A, Santos Prata T. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it? Can J Ophthalmol 2015;50:297-301. [PMID: 26257224 DOI: 10.1016/j.jcjo.2015.03.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2014] [Revised: 03/13/2015] [Accepted: 03/22/2015] [Indexed: 10/23/2022]

For:	Juncal VR, Abdo Jorge F, Paranhos A, Santos Prata T. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it? Can J Ophthalmol 2015;50:297-301. [PMID: 26257224 DOI: 10.1016/j.jcjo.2015.03.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2014] [Revised: 03/13/2015] [Accepted: 03/22/2015] [Indexed: 10/23/2022]

Number

Cited by Other Article(s)

Costa VP, Aung T, Konstas AG. Evolution of the treatment paradigm for maximum medical therapy in glaucoma. EXPERT REVIEW OF OPHTHALMOLOGY 2019. [DOI: 10.1080/17469899.2019.1570138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]